Get started
Work

Individual Natriuretic and Diuretic Response in Acute Heart Failure: Insights from the PUSH-AHF Pharmacologic Substudy

Year: 2025
Type: article
Abstract: The employer of IEB receives speaker fees by Novartis. JMtM is supported by a Dekker grant of the Dutch Heart Foundation (2020T012) for this study and declares speaker/consulting fees to institution from Bayer, Boehringer Ingelheim, Johnson and Johnson, Moderna, Novartis, Novo Nordisk, and Roche. PvdM is supported by a grant from the European Research Council (ERC CoG 101045236, DISSECT-HF). The UMCG, which employs PvdM, received consultancy fees and/or grants from Novartis, Pharmacosmos, Vifor Pharma, Astra Zeneca, Pfizer, Pharma Nord, BridgeBio, Novo Nordisk, Daiichi Sankyo, Boehringer Ingelheim and Ionis.
DOI: 10.1016/j.cardfail.2025.04.015
Authors: IRIS E. BELDHUIS, JOZINE M. TERMAATEN, PETER VAN DER MEER, JENIFER E. COSTER, LUKAS BAUMHOVE, JAN A. KRIKKEN, WYBE NIEUWLAND, DIRK J. VAN VELDHUISEN, ADRIAAN A. VOORS, KEVIN DAMMAN
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,970
Funders: Pfizer, AstraZeneca, Bayer, Moderna, Hartstichting, Novo Nordisk, Universitair Medisch Centrum Groningen, Vifor Pharma, Daiichi Sankyo Europe, HORIZON EUROPE European Research Council
OpenAlex ID: W4410635290
FWCI: 0.629
Cites: 8
Cited by: 1
Related to: 10